期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

基于NMR的代谢组学技术在疾病诊断研究中的应用 被引量：1

Application of Metabonomics Techniques Based on Nuclear Magnetic Resonance in Diagnostic Study on Diseases
下载PDF
导出
摘要 代谢组学作为一种比较新颖的组学技术,在医学界也逐渐开始运用,尤其是在疾病诊断中已经取得了一定的成果。本文主要对代谢组学在医学疾病诊断中的研究现状进行综述,以供医学工作者参阅。 As one kind of the newest ＂-nomics＂ methods, metabonomics technique is gradually applied in medicine, especially in the diagnosis of some diseases. In this article we have summarized the research status on metabonomics for the diagnosis of some diseases in order to supply medical personnels a reference.
作者 郭玲玲 吴巧凤 李亮 卢圣锋 袁成凯 彭静 唐勇
机构地区 成都中医药大学时间生物实验室
出处 《现代诊断与治疗》 CAS 2007年第4期227-231,共5页 Modern Diagnosis and Treatment
基金 四川省教育厅重点实验室项目 项目编号:200ZD014
关键词 代谢组学 疾病诊断 Metabonomics Diagnosis of diseases
分类号 R446 [医药卫生—诊断学]
  • 相关文献

参考文献39

  • 1Nicholson JK,Connelly J,Lindon JC,et al.Metabonomics:a platform for studying drug toxicity and gene function[J].Nat Rev Drug Discov,2002,1:153-162.
  • 2Mountford CE,Doran S,Lean CL,et al.Cancer pathology in the year 2000[J].Biophy Chem,1997,68:127-135.
  • 3Brindle JT,Antti H,Holmes E,et al.Rapid and noninvasive diagnosis of the presence and severity of coronary heart disease using 1H-NMR-based metabonomics[J].Nat Med,2002,8:1439-1444.
  • 4Kostara CH,Papathanasiou A,Cung MT,et al.Total plasma lipid analysis in patients with established coronary heart disease by 1H-NMR spectroscopy[C].75th EAS Congress,2005.23-26.
  • 5Bathen TF,Engan T,Krane J,et al.Analysis and classification of proton NMR spectra of lipoprotein fractions from healthy volunteers and patients with cancer or CHD[J].Anticancer Res,2000,20(4):2393-2408.
  • 6Bowden RG,Leutholtz BC,Wilson R,et al.NMR Lipoprofile,changing the way coronary heart disease(CHD) lipoprofile is Assessed and managed in end-stage renal disease[J].Med Sci in Sports Exere,2004,36(5):160.
  • 7Howells SL,Maxwell RJ,Howe FA,et al.Pattern recognition of 31P magnetic resonance spectroscopy tumor spectra obtained in vivo[J].NMR Biomed,1993,6(4):237-241.
  • 8Beckonert O,Monnerjahn J,Bonk U,et al.Visualizing metabolic changes in breast-cancer tissue using 1H-NMR spectroscopy and self-organizing maps[J].NMR Biomed,2003,16(1):1-11.
  • 9Katz-Brull R,Seger D,Rivenson-Segal D,et al.Metabolic markers of breast cancer enhanced choline metabolism and reduced choline-ether-phospholipid synthesis[J].Cancer Res,2002,62(7):1966-1970.
  • 10Griffiths JR,McSheehy PM,Robinson SP,et al.Metabolic changes detected by in vivo magnetic resonance studies of HEPA-1 wild-type tumors and tumors deficient in hypoxia-inducible factor-1p (HIF-1p):evidence of an anabolic role for the HIF-1 pathway[J].Cancer Res,2002,62(3):688-695.

二级参考文献61

  • 1郭栩,薛俊,张岩,林炳承.毛细管无胶筛分电泳[J].生物化学与生物物理进展,1995,22(5):403-407. 被引量：16
  • 2黄卫华 庞代文 zF宗礼.Chem．J．Chinese Universities(高等学校化学学报)[J],2001,22(9):1-1.
  • 3[1]Xu G, Stefano CD, Liebich HM, et al. Reversed_phase high_performance liquid chromatographic investigation of urinary normal and modified nucleosides of cancer patients[J]. J Chromatogr,1999, 732: 307-313.
  • 4[2]Liebich HM, Xu GW, Stefanoc CD, et al. Capillary electrophoresis of urinary normal and modified nucleosides of cancer patient[J]. J Chromatogr, 1998, 793: 341-347.
  • 5[3]Torgny R, Glenn RB.Urinary excretion of pseudouridine and prognosis of patients with malignant lyphoma[J]. Acta Oncologica,1995, 34: 61-67.
  • 6[4]Xu G, Schmid HR, Lu X,et al. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP HPLC and factor analysis method[J]. Biomed Chromatogr, 2000, 4:1-5.
  • 7Ames B, N., Free Rad. Res, Commun, [J], 1987, 7:121--128.
  • 8Adelman R. , Saul R. L. , Ames B. N. Proc. Natl. Acad. Sci. USA[J], 1988, 85:2 706--2 708.
  • 9Kuchino Y. , Mori F. , Kasai H. et al. Nature[J], 1987, 327:77--79.
  • 10Shibutani S. , Takeshita M. , Grollman A. P. Nature[J], 1991, 349:431--434.

共引文献55

同被引文献4

引证文献1

现代诊断与治疗
2007年 第4期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部